HIV Prevention Education:

Dear Pharmacist,

Ending HIV is a vision where new HIV infections can be eliminated, and all people living with HIV have access to high-quality care, free from stigma and discrimination. HIV prevention focuses on old and new prevention interventions, including condom distribution, syringe exchange, and HIV Prevention medications; Pre-Exposure Prophylaxis (PrEP), and Post-Exposure Prophylaxis (PEP).

Pharmacists can help meet the goals of ending HIV by reducing disparities in access to HIV Prevention medications and reducing new HIV diagnoses.

Trauma-Informed Care

The populations experiencing inequities in access to PEP and PrEP treatments are also those most impacted by health inequities, health disparities, and social determinants of health.

A person seeking HIV PEP may have recently gone through a traumatic event such as a sexual assault or occupational needle stick. Folks seeking PrEP may have had negative and traumatic experiences with the healthcare system. Trauma-informed care acknowledges the need to understand a person's life experiences to deliver effective care and has the potential to improve patient engagement, treatment adherence, and health outcomes. Using a trauma-informed approach creates a safe environment in the pharmacy for those seeking PEP and PrEP.

Accreditation Council for Pharmacy Education Information:

This program has been planned and implemented in accordance with the policies of the Accreditation Council for Pharmacy Education through the sponsorship of OSU College of Pharmacy. The OSU College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Upon completion of this activity, participants will receive a Statement of Completion, and a Statement of Credit shall be uploaded to CPE Monitor. Completion requires 1) Registration for the course 2) Completion of all modules 3) Passing a final exam with 80% or higher and 4) Completion of the program evaluation.

At the completion of this activity, the participant will be able to:

1. Distinguish methods of HIV prevention, focusing on PrEP and PEP
2. Describe HIV epidemiology in the United States
3. Review the HIV life cycle, disease progression, transmission, and risk
4. Recognize how health inequities impact health and healthcare disparities
5. Recall the signs and symptoms of trauma, specifically as it relates to PrEP and PEP care
6. Apply the concept of trauma-informed care to patient cases
7. Asses risk for HIV acquisition
8. Review HIV PrEP and HIV PEP eligibility and exclusion criteria for pharmacists
9. Describe HIV PrEP and HIV PEP medications regimens, side effects, and drug interactions
10. Discuss HIV testing, including CLIA waiver, HIV Ag/Ab POC testing process, delivery of test results, and disease reporting
11. Apply the process of assessing a patient for HIV PrEP or HIV PEP through case examples
12. Differentiate when to use HIV PrEP vs HIV PEP using a case example
13. Examine special cases in HIV PrEP and HIV PEP in which the pharmacist must make a referral
14. Utilize resources for troubleshooting difficult cases
15. Implement HIV Prevention services in the pharmacy
16. Explain how to bill for HIV PrEP and HIV PEP services

UAN: 0036-0000-23-005-H02-P
Activity Type: Application
Activity Release Date: 04/01/2023
Activity Expiration Date: 04/01/2026
Authors/Faculty: Marie Dorsey, PharmD, BCPS, AAHIVP; Geoff L'Heureux, PharmD, AAHIVP; Sharon Rask, RPh
Disclosures: None of the faculty, contributors, designers, or peer reviewers for this course have any financial relationships with ineligible companies to disclose